Genome-Informed Targeted Therapy for Osteosarcoma-Reference-Cited by-同舟云学术

Genome-Informed Targeted Therapy for Osteosarcoma

Published:2018-09-28 Issue: Volume: Page:CD-17-1152
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Sayles Leanne C,Breese Marcus R,Koehne Amanda L,Leung Stanley G,Lee Alex G,Liu Heng-Yi,Spillinger Aviv,Shah Avanthi Tayi,Tanasa Bogdan,Straessler Krystal,Hazard Florette K,Spunt Sheri L.,Marina Neyssa,Kim Grace E.,Cho Soo-Jin,Avedian Raffi S,Mohler David G,Kim Mi-Ok^ORCID,Dubois Steven G,Hawkins Douglas S.,Sweet-Cordero E. Alejandro

Funder

HHS | National Institutes of Health (NIH)

Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels (Hope On Wheels)

Stanford University School of Medicine (Stanford School of Medicine, Stanford University)

St. Baldrick's Foundation

CureSearch for Children's Cancer

Sarcoma Foundation of America (SFA)

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances on immunotherapy for osteosarcoma;Molecular Cancer;2024-09-09

2. Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway;Cancer Chemotherapy and Pharmacology;2024-09-05

3. Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft models;Scientific Reports;2024-08-27

5. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas;Scientific Reports;2024-08-20